Evidence map›Paper›PMID 29147759›Full record

ReviewWorld journal of urology2018

Patterns and predictors of recurrence after open radical cystectomy for bladder cancer: a comprehensive review of the literature.

Andrea Mari, Riccardo Campi, Riccardo Tellini, Giorgio Gandaglia, Simone Albisinni, Mohammad Abufaraj, Georgios Hatzichristodoulou, Francesco Montorsi, Roland van Velthoven, Marco Carini and 2 more

Open access · hybridAbstract readReview
In one paragraph

Review in World journal of urology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 120 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Nanoemulsion-enhanced cytotoxicity ofFrontiers in oncology · 2026
    Article
  8. Current Status and Future Perspectives of Molecular Residual Disease Testing in Genitourinary Cancers.International journal of urology : official journal of the Japanese Urological Association · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 5 countries.

Andrea MariDepartment of Urology, University of Florence, Careggi Hospital, Florence, Italy.
Riccardo CampiDepartment of Urology, University of Florence, Careggi Hospital, Florence, Italy.
Riccardo TelliniDepartment of Urology, University of Florence, Careggi Hospital, Florence, Italy.
Giorgio GandagliaDivision of Oncology/Unit of Urology, IRCCS San Raffaele Hospital, URI, Milan, Italy.
Simone AlbisinniDepartment of Urology, Institut Jules Bordet, Université Libre de Bruxelles, Bruxelles, Belgium.
Mohammad AbufarajDepartment of Urology, Medical University of Vienna, Vienna, Austria.
Georgios HatzichristodoulouDepartment of Urology and Pediatric Urology, Julius-Maximilians-University of Würzburg, Würzburg, Germany.
Francesco MontorsiDivision of Oncology/Unit of Urology, IRCCS San Raffaele Hospital, URI, Milan, Italy.
Roland van VelthovenDepartment of Urology, Institut Jules Bordet, Université Libre de Bruxelles, Bruxelles, Belgium.
Marco CariniDepartment of Urology, University of Florence, Careggi Hospital, Florence, Italy.
Andrea MinerviniDepartment of Urology, University of Florence, Careggi Hospital, Florence, Italy.
Shahrokh F ShariatDepartment of Urology, Medical University of Vienna, Vienna, Austria. shahrokh.shariat@meduniwien.ac.at.
University of Florence · ITMedical University of Vienna · ATUniversité Libre de Bruxelles · BEIstituto di Ricovero e Cura a Carattere Scientifico San RaffaeleKarl Landsteiner Society · ATUniversity of Würzburg · DEVita-Salute San Raffaele University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo review the currently available literature reporting the patterns of recurrence and their predictive factors after open radical cystectomy (RC) for bladder cancer.

methodsA review of the literature was performed using the MEDLINE, Scopus and Web of Sciences databases from January 1997 to May 2017. The PRISMA guidelines were followed for the conduct of the study.

resultsLocal recurrence rate ranges between 30 and 54%. Distant recurrence is not often standardized and is reported in up to 50% of cases. The overall 5-year recurrence-free survival rates from 58 to 81%. The mean follow-up of studies included in the analysis ranged from 18 to 350 months. Details on the most important demographic and epidemiological, clinical, histologic and pathologic predictors of recurrence after radical cystectomy are provided through an evidence-based approach. The impact of the extension of lymph node dissection on recurrence after RC is investigated.

conclusionsA correct prognostic assessment is essential for patients undergoing radical cystectomy for bladder cancer, thereby potentially improving their oncologic outcomes.

Indexed as

Antineoplastic AgentsCarcinoma, Transitional CellChemotherapy, AdjuvantCystectomyDisease-Free SurvivalHumansLymph Node ExcisionNeoadjuvant TherapyNeoplasm Recurrence, LocalPrognosisRadiotherapyRadiotherapy, AdjuvantRisk FactorsUrinary Bladder NeoplasmsAntineoplastic AgentsAdjuvant chemotherapyBladder cancerLymph node dissectionNeoadjuvant chemotherapyRadical cystectomyRecurrence

Identifiers

PMID29147759
PMCPMC5799348
OpenAlexW2768465438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.